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OBJECTIVE—Obesity impairs adiponectin expression, assembly,
and secretion, yet the underlying mechanisms remain elusive. The
aims of this study were 1) to determine the molecular mechanisms
by which obesity impairs adiponectin multimerization and
stability, and 2) to determine the potential role of disulﬁde-
bond-A oxidoreductase-like protein (DsbA-L), a recently iden-
tiﬁed adiponectin interactive protein that promotes adiponectin
multimerization and stability in obesity-induced endoplasmic retic-
ulum (ER) stress and adiponectin downregulation.
RESEARCH DESIGN AND METHODS—Tauroursodeoxy-
cholic acid (TUDCA), a chemical chaperone that alleviates ER
stress, was used to study the mechanism underlying obesity-
induced adiponectin downregulation in db/db mice, high-fat
diet-induced obese mice, and in ER-stressed 3T3-L1 adipocytes.
The cellular levels of DsbA-L were altered by RNAi-mediated
suppression or adenovirus-mediated overexpression. The protec-
tive role of DsbA-L in obesity- and ER stress–induced adiponec-
tin downregulation was characterized.
RESULTS—Treating db/db mice and diet-induced obese mice
with TUDCA increased the cellular and serum levels of adiponec-
tin. In addition, inducing ER stress is sufﬁcient to downregulate
adiponectin levels in 3T3-L1 adipocytes, which could be pro-
tected by treating cells with the autophagy inhibitor 3-methylad-
enine or by overexpression of DsbA-L.
CONCLUSIONS—ER stress plays a key role in obesity-induced
adiponectin downregulation. In addition, DsbA-L facilitates adi-
ponectin folding and assembly and provides a protective effect
against ER stress–mediated adiponectin downregulation in
obesity. Diabetes 59:2809–2816, 2010
A
diponectin is an insulin sensitizer that plays a
versatile role in the regulation of energy ho-
meostasis and insulin sensitivity. The serum
adiponectin levels are signiﬁcantly reduced un-
der the conditions of obesity, insulin resistance, and type
2 diabetes (1), yet the precise underlying mechanisms
remain largely unknown.
Adiponectin is synthesized as a single polypeptide of 30
kDa and is then assembled in the endoplasmic reticulum
(ER), primarily into three species: trimer, hexamer, and
high molecular weight (HMW) multimer (2–5). The differ-
ent forms of adiponectin have been found to play distinct
roles in the regulation of energy homeostasis (2–4,6).
Several ER-associated proteins, including Ero1-l, ERp44,
and GPR94, have recently been found to be involved in the
assembly and secretion of higher-order adiponectin com-
plexes (5,7,8). Impairment in adiponectin multimerization
affects both secretion and function of this adipokine, and
is associated with diabetes and hypoadiponectinemia
(2,4).
ER is a eukaryotic organelle responsible for several
specialized and important functions such as protein
translation, folding, and transport of membrane or se-
creted proteins. Numerous protein chaperones are
present in the ER lumen that yield an oxidizing environ-
ment necessary for correct folding and assembly of
various membrane and secretive proteins such as adi-
ponectin. In obesity, increased demand on ER function
leads to ER stress and the unfolded protein response
(UPR) to ensure that normal cell function and viability
are maintained (9). However, whether and how ER
stress plays a role in obesity-induced adiponectin down-
regulation remain to be established.
We recently identiﬁed an adiponectin-interacting pro-
tein named disulﬁde-bond A oxidoreductase-like protein
(DsbA-L) (10). DsbA-L is expressed in various mouse
tissues such as liver, kidney, pancreas, and heart, but the
highest expression of this protein is detected in adipose
tissue where adiponectin is synthesized and secreted (10).
The cellular levels of DsbA-L are signiﬁcantly reduced in
adipose tissues of obese mice and human subjects. Over-
expression of DsbA-L promotes adiponectin multimeriza-
tion while reducing DsbA-L expression by RNAi markedly,
and selectively reduces adiponectin levels and secretion
in 3T3-L1 adipocytes (10). However, how DsbA-L regu-
lates adiponectin multimerization and stability remains
unknown.
In the present study, we show that alleviating ER stress
enhances the cellular and plasma levels of adiponectin in
both db/db mice and diet-induced obese mice. In addition,
we demonstrate that inducing ER stress is sufﬁcient to
downregulate the cellular levels and secretion of adi-
ponectin in 3T3-L1 adipocytes. Furthermore, overexpres-
sion of DsbA-L suppresses the inhibitory effect of ER
stress on adiponectin multimerization and stability. Our
studies demonstrate that ER stress is a key factor in
obesity-induced downregulation of adiponectin and that
increasing the cellular levels of DsbA-L improves adi-
ponectin assembly and stability by suppressing the nega-
tive effect of ER stress.
RESEARCH DESIGN AND METHODS
Chemicals and antibodies. The following chemicals were used: thapsigargin
(TG) (350–004, Alexis Biochemicals, San Diego, CA), 3-methyladenine (3-MA)
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diabetes.diabetesjournals.org DIABETES, VOL. 59, NOVEMBER 2010 2809(M9281, Sigma-Aldrich), tauroursodeoxycholic acid ([TUDCA] 580549, Calbio-
chem, Gibbstown, NJ), and G418 sulfate (30–234-CR, Cellgro, Manassas, VA).
Polyclonal antiadiponectin and DsbA-L antibodies were generated as de-
scribed before (10). Antibodies against -actin, AMP-activated protein kinase
(AMPK), phosphor-Thr
172-AMPK, Acetyl-CoA carboxylase, phosphor-Ser
79-
Acetyl-CoA carboxylase, and anti-LC3 were from Cell Signaling Technology
(Danvers, MA). Other antibodies used were: monoclonal antiadiponectin
(MAB3608, Chemicon International), anti--tubulin 2.1 (T4026, Sigma-Al-
drich), and anti-GADD 153/CHOP (sc-7351, Santa Cruz Biotechnology, Santa
Cruz, CA).
Cell culture, differentiation and adenovirus infection. The culture of
C2C12 cells and the murine hepatocytes was described in our previous studies
(11,12). The 3T3-L1 cells stably expressing enhanced green ﬂuorescent protein
(EGFP)-LC3 were generated by transfection of cells with the pEGFP-LC3
plasmid, a gift from Dr. Jean X. Jiang (University of Texas Health Science
Center at San Antonio), and selection with 400 g/ml of G418. Independent
clones were selected by limited dilution. Next, C2C12 and 3T3-L1 cell
differentiation were performed as described in our previous studies (10,11).
Adenoviruses encoding GFP and GFP plus wild type or S16A mutant of
DsbA-L were described in our previous studies (10).
Animal studies. Male db/db mice and their lean controls (stock# 000642,
3–5 weeks old) were purchased from Jackson Laboratories (Bar Harbor,
ME). The mice were group-housed in a speciﬁc-pathogen–free facility at 22
to 24°C on a 12-h light/12-h dark cycle with the lights on at 8:00 A.M. The
mice were fed with standard rodent chow, and all animals had access to
water ad libitum. At 8 weeks of age, the mice were intraperitoneally
injected with TUDCA (250 mg/kg) or equal volumes of vehicle (saline)
twice daily (at 8:00 A.M. and 8:00 P.M.) for 26 days. Mice were then killed and
mouse tissues were isolated according to the procedure described in our
recent studies (13). For high-fat diet (HFD) experiments, 6- to 8-week-old
C57BL/6 mice (10 mice per group) were fed with regular chow diet
(Research Diets #D12328: 10.5 kcal% fat, 73.1 kcal% carbohydrate, and 16.4
kcal/% protein) or HFD (Research Diets #D12330: 58.0 kcal% fat, 16.0
kcal/% protein, and 26 kcal% carbohydrate) for 5 months. During the last 3
weeks of the HFD feeding period, the mice were intraperitoneally injected
with TUDCA (250 mg/kg) or equal volumes of vehicle (saline) twice daily
(8:00 A.M. and 8:00 P.M.). Mice were killed, and mouse tissues were isolated
according to the procedure described in our recent studies (13). All animal
procedures were approved by the University of Texas Health Science
Center Animal Care and Use Committee.
Insulin tolerance test. The saline- and TUDCA-treated male db/db mice and
lean control mice (8–10 mice per group) were fasted for 6 h followed by
insulin injection (2 IU/kg animal body weight i.p.). Blood was obtained from
the tail vein before (0 min) and after insulin injection (15, 30, 60, and 120 min).
Glucose levels were measured using an automatic glucometer (Rightest
GM300; Bionime Corp, San Diego, CA).
Determination of adiponectin multimers. Adiponectin multimers were
determined by gel ﬁltration fast-protein liquid chromatography with a Super-
dex 200 10/30 column (GE Healthcare Bio-Sciences, Piscataway, NJ), as
described in our previous study (10).
Immunoﬂuorescence study and Western blot studies. The immunoﬂuo-
rescence and Western blot studies were performed as previously described
(10,14). The localization and expression of adiponectin were visualized with
an Olympus IX 81 confocal microscope with a 40X, 1.35 NA oil immersion
objective. Quantiﬁcation of the relative change in protein levels detected by
Western blot (expressed as a percentage of control protein levels, arbitrarily
set as 1.0) was performed by analyzing Western blots using the Scion Image
Alpha 4.0.3.2 program (Scion Corporation) and was normalized for the
amount of protein loaded in each experiment.
Quantitative real-time PCR. Adiponectin mRNA was puriﬁed mRNA from
cells using TRIZOL reagent (Invitrogen). Total RNA was reverse transcribed
using SuperScript III First-Strand Synthesis Supermix (Invitrogen). The cDNA
samples were ampliﬁed in duplicate in 96-microtiter plates (Applied Biosys-
tems). Each PCR reaction (20 l total volume) contained: 10 l of SYBR Green
PCR Master Mix (Applied Biosystems), 5 pmols of each primer, and 1 go f
cDNA. The PCR primers for adiponectin were: 5-CCC AAG GGA ACT TGT
GCA GGT TGG ATG-3 and 5-GTT GGT ATC ATG GTA GAG AAG AAA
GCC-3. The mRNA of glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
was quantiﬁed as an endogenous control, using the following primers:
5-ACCACAGTCCATGCCATCAC-3 and 5-TCCACCACCCTGTTGCTGTA-3.
Real-time PCR reactions were carried out in an ABI PRISM 7,700 real-time
PCR apparatus. Reactions without a template or without the reverse tran-
scriptase were used as negative controls.
Statistical analysis. Statistical analysis of the data were performed using
ANOVA. Statistical signiﬁcance was set at P values of * 0.05, ** 0.01, and
*** 0.001.
RESULTS
Reduction of ER stress increases adiponectin levels
in obese mice and in cells. Obesity induces ER stress,
and ER stress is correlated with reduced adiponectin
levels (15). To determine whether ER stress is involved in
downregulating adiponectin expression in obesity, we
examined adiponectin levels in db/db mice treated with
vehicle or the ER stress–reducing chemical chaperone,
TUDCA. Obesity led to a great increase in ER stress in fat
tissue of the db/db mice, as demonstrated by increased
C/EBP-homologous protein (CHOP) expression (Fig. 1A).
Concurrent with increased ER stress, the cellular (Fig. 1B)
and circulating (Fig. 1C) levels of adiponectin were signif-
icantly reduced in the db/db mice compared with that of
the lean mice. Treating the db/db mice with TUDCA greatly
reduced obesity-induced CHOP expression, concurrent
with an increase in circulating and cellular levels of
adiponectin and its interacting protein DsbA-L (Fig. 1A–
D). TUDCA treatment had no signiﬁcant effect on the food
intake (data not shown) (16) and body weight of the db/db
mice (supplementary Fig. S1A in the appendix available
online at http://diabetes.diabetesjournals.org/cgi/content/
full/db10-0412/DC1, indicating that the TUDCA-mediated
rescuing effect on DsbA-L and adiponectin levels was not
a consequence of altered food intake/body weight. The
expression levels of DsbA-L and adiponectin were also
greatly reduced in WAT of HFD-induced obese mice (10)
and this reduction was also rescued by TUDCA treatment
(supplemental online Fig. S2). Taken together, these re-
sults suggest that ER stress may play a key role in
obesity-induced adiponectin downregulation.
DsbA-L prevents ER stress–induced adiponectin
downregulation in 3T3-L1 adipocytes. To determine
whether ER stress is sufﬁcient to reduce adiponectin
levels, we examined adiponectin expression in 3T3-L1
adipocytes treated with and without thapsigargin (TG), a
chemical widely used to stimulate ER stress by inhibiting
ER calcium-ATPase (17). Treating 3T3-L1 adipocytes with
TG led to a marked increase in ER stress, as demonstrated
by enhanced CHOP expression (Fig. 1E). TG treatment
also greatly reduced the cellular levels of adiponectin and
DsbA-L as well as adiponectin secretion into the medium,
which could be partially prevented by pretreating the cells
with TUDCA (Fig. 1E). Although inducing ER stress by TG
led to an 25% reduction in the mRNA levels of adiponec-
tin, treating 3T3-L1 adipocytes with TUDCA had no signif-
icant rescuing effect on the TG-induced downregulation of
the mRNA levels of adiponectin (Fig. 1F). On the other
hand, TG treatment led to a 60% reduction in the protein
levels of adiponectin and the TG-induced downregulation
of adiponectin was signiﬁcantly protected by treating the
cells with TUDCA (Fig. 1G), suggesting that the protective
effect of DsbA-L on cellular levels of adiponectin is mainly
at the protein level rather than mRNA level. TG treatment
had no signiﬁcant effect on the expression levels of two
other adipokines, tumor necrosis factor- (TNF) and
resistin (Fig. 1E), suggesting a selective role of this ER
stress inducer in adipokine stability.
Since DsbA-L levels are negatively associated with obe-
sity (10) and ER stress (Fig. 1), we were interested in
determining whether reducing the expression levels of
DsbA-L contributes to ER stress–induced adiponectin
downregulation. To test this, we examined UPR, which is
induced by ER stress, in scramble and three independent
DsbA-L–suppressed 3T3-L1 cells. In agreement with our
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were greatly suppressed in the DsbA-L–suppressed 3T3-L1
adipocytes (Fig. 2A, top panel). Interestingly, UPR was
markedly increased in the DsbA-L–suppressed cells, as
demonstrated by increased expression of the UPR marker
CHOP (Fig. 2A, third panel). Taken together with our
previous ﬁnding that suppressing DsbA-L expression in
3T3-L1 adipocytes greatly reduced the protein, but not the
Adpn 
β-actin
Lean; Saline  TUDCA 
db/db 
CHOP
S
e
r
u
m
 
W
A
T
 
Adpn 
IgG 
Saline 
A
BC
Lean  db/db 
+TUDCA 
db/db 
** 
** 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
C
e
l
l
u
l
a
r
 
a
d
i
p
o
n
e
c
t
i
n
l
e
v
e
l
 
(
A
r
b
i
t
r
a
r
y
 
u
n
i
t
)
 
Lean db/db 
+TUDCA 
db/db 
*** 
*** 
?
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
1.4 
D
DsbA-L 
C
i
r
c
u
l
a
t
i
n
g
 
a
d
i
p
o
n
e
c
t
i
n
 
l
e
v
e
l
 
(
A
r
b
i
t
r
a
r
y
 
u
n
i
t
)
 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
Lean  db/db  
+TUDCA 
db/db 
***  
*** 
A
r
b
i
t
r
a
r
y
 
D
s
b
A
-
L
 
l
e
v
e
l
 
Tubulin 
CHOP 
DsbA-L 
Adpn 
TG - + +     
TUDCA  -- +
E
TNFα
Resistin 
Adpn  Medium 
Cell 
Lysates 
G
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
Ctrl 
TG 
TUDCA+TG 
R
e
l
a
t
i
v
e
 
A
d
p
n
 
p
r
o
t
e
i
n
 
l
e
v
e
l
 
***  
** 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
Ctrl 
TG 
TUDCA+TG 
R
e
l
a
t
i
v
e
 
A
d
p
n
 
m
R
N
A
 
l
e
v
e
l
 
*  F
ns 
FIG. 1. Suppression of ER stress improves adiponectin expression in db/db mice. A: The expression levels of adiponectin (Adpn), DsbA-L, and
CHOP in white adipose tissue (WAT) and the serum adiponectin levels from saline- or TUDCA-treated lean or db/db mice were determined by
Western blot with speciﬁc antibodies as indicated. -actin or immunoglobulin (IgG) was used as a tissue or serum loading control, respectively.
The relative protein levels of adiponectin in WAT (B), or in serum (C), and DsbA-L (D) were quantiﬁed. Data represent mean  SEM. **P < 0.01,
***P < 0.001; n  10 for the saline control mice, and n  8 per treatment group for the db/db mice. E: Differentiated 3T3–L1 adipocytes were
pretreated with or without TUDCA (1 mmol/l) for 1 h followed with TG (0.01 mol/l) cotreatment for 24 h. The cells were lysed, and the
expression levels of adiponectin, DsbA-L, CHOP, TNF, resistin, and -tubulin were determined by Western blot analysis with speciﬁc antibodies
as indicated. Adiponectin levels in conditioned medium were determined with an antiadiponectin antibody. F: The mRNA levels of adiponectin
were determined by quantitative reverse transcription PCR. The protein levels of adiponectin as shown in (E) were quantiﬁed (G). N  3, *P <
0.05, **P < 0.01, ***P < 0.001; ns, no statistical difference; ctrl, control.
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that downregulation of DsbA-L may lead to accumulation
of incorrectly folded proteins that in turn induces UPR.
Consistent with this, overexpression of DsbA-L–sup-
pressed CHOP expression and enhanced resistance to ER
stress–induced adiponectin downregulation in 3T3-L1 CAR
adipocytes (Fig. 2B).
To determine the role of the DsbA-L in ER stress–
induced dysregulation of adiponectin multimerization, we
studied adiponectin multimer distribution by gel ﬁltration
in 3T3-L1-CAR adipocytes. To better compare the effects
of TG on the relative distributions of various adiponectin
multimers, equal amounts of adiponectin from TG-treated
and nontreated 3T3-L1-CAR cells were analyzed by West-
ern blot. In 3T3-L1-CAR adipocytes overexpressing GFP
control, the majority of the adiponectin multimers is the
HMW form (Fig. 2C, top panel, and D). Induction of ER
stress by TG treatment led to marked reduction of the
HMW form of adiponectin, which was alleviated by over-
expression of wild-type but not the S16A mutant of DsbA-L
(Fig. 2C and D). Overexpression of the S16A mutant of
DsbA-L failed to protect ER stress–induced downregula-
tion of cellular and secreted adiponectin (Fig. 2E). Since
the DsbA-L
S16A mutant is unable to bind to adiponectin
(10), these ﬁndings suggest that the interaction with
adiponectin is critical for the protective effect of DsbA-L.
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FIG. 2. DsbA-L suppresses ER stress and improves adiponectin expression and multimerization. A: The expression levels of adiponectin, DsbA-L,
and CHOP in DsbA-L–suppressed or scramble control 3T3–L1 adipocytes were determined by Western blot with speciﬁc antibodies. -tubulin was
used as a loading control. The data represent three independent experiments with similar results. B: The 3T3–L1-CAR adipocytes were infected
with adenovirus encoding DsbA-L or GFP for 24 h. The cells were then treated with or without TG (0.01 mol/l) for various times as indicated.
The expression levels of adiponectin, CHOP, and myc-DsbA-L in cell lysates were determined by Western blot with speciﬁc antibodies as
indicated. -tubulin was used as a loading control. The data represent three independent experiments with similar results. C: The 3T3–L1-CAR
adipocytes were infected with adenovirus encoding GFP, DsbA-L, or the S16A mutant of DsbA-L for 24 h. The cells were then treated with or
without TG (0.01 mol/l) for 24 h as indicated. Adiponectin multimers in cell lysates were separated by gel ﬁltration and determined by Western
blot with an antiadiponectin antibody. The percentages of HMW form in total adiponectin (D) were quantiﬁed (n  3, *P < 0.05, **P < 0.01,
***P < 0.001). E: The 3T3–L1-CAR adipocytes were infected with adenoviruses encoding myc-tagged wild-type (WT) or the S16A mutant of
DsbA-L for 24 h. The cells were then treated with or without TG (0.01 mol/l) for 24 h. The adiponectin levels in conditioned medium (C.M.) and
the expression levels of adiponectin, myc-DsbA-L or DsbA-L
S16A, and CHOP were determined by Western blot with speciﬁc antibodies as
indicated. -tubulin was used as a loading control. F: The mRNA levels of adiponectin were determined by quantitative reverse transcription PCR.
N  3, *P < 0.05; ns, no statistical difference.
ADIPONECTIN DOWNREGULATION
2812 DIABETES, VOL. 59, NOVEMBER 2010 diabetes.diabetesjournals.orgOur results also demonstrated that overexpression of
either wild-type or the S16A mutant of DsbA-L had no
signiﬁcant protecting effect on the mRNA levels of adi-
ponectin (Fig. 2F). On the other hand, the protein levels of
adiponectin were signiﬁcantly increased in cells overex-
pressing wild-type DsbA-L (Fig. 2E). Taken together, these
results provide further evidence that the rescuing effect of
DsbA-L on cellular levels of adiponectin is mainly at the
post-translational level.
Adiponectin is downregulated in DsbA-L–suppressed
cells via autophagy-dependent degradation. We re-
cently found that autophagy plays a critical role in ER
stress–induced insulin receptor downregulation (18).
Since ER stress is induced in DsbA-L–suppressed cells
(Fig. 2A), we asked whether autophagy is involved in the
downregulation of adiponectin expression in these cells.
The levels of LC3-II, an autophagy marker protein, were
noticeably increased in the DsbA-L–suppressed 3T3-L1
adipocytes compared with the scramble control cells (Fig.
3A). Pretreating the DsbA-L–suppressed adipocytes with
the autophagy inhibitor 3-MA, but not the protesome
inhibitor MG-132, greatly suppressed LC3 expression and
signiﬁcantly blocked DsbA-L deﬁciency-induced adiponec-
tin protein downregulation (Fig. 3A and data not shown).
A rescuing effect of 3MA on the total levels of adiponectin
was also observed in TG-treated 3T3-L1 adipocytes (Fig.
3B). However, despite elevated cellular adiponectin levels,
adiponectin secretion was not signiﬁcantly increased by
the 3MA treatment (Fig. 3A and B, top panel). One possible
explanation for these results is that most of the rescuing
adiponectin molecules were not correctly folded in the
DsbA-L–deﬁcient cells and thus unable to pass the ER-
Golgi quality control system for secretion. The 3-MA
treatment had no signiﬁcant rescuing effect on adiponectin
mRNA levels (Fig. 3C), consistent with an inhibitory role
of 3MA in autophagy-induced protein degradation. Immu-
noﬂuorescence studies revealed that ER stress promoted
adiponectin translocation to the autophagosome, which is
evident by increased colocalization of the adiponectin
signal with the punctate LC3 staining (Fig. 3D, bottom
panel). No major punctate LC3 ﬂuorescent autophago-
some signal could be detected in the control cells (Fig. 3D,
top panels). These results provide further evidence on the
involvement of an autophagy-dependent pathway in ER
stress–induced adiponectin degradation.
Alleviating ER stress improves AMPK signaling and
insulin sensitivity in db/db mice. Adiponectin activates
AMPK, which in turn phosphorylates and inactivates
acetyl-CoA carboxylase (ACC) to regulate fatty acid oxi-
dation (19). Based on the ﬁnding that alleviating ER stress
increased adiponectin expression levels and secretion in
db/db mice (Fig. 1), we examined the effect of TUDCA on
AMPK and ACC phosphorylation. We found that AMPK
activation, as indicated by Thr
172 phosphorylation, was
signiﬁcantly increased in the skeletal muscle of the
TUDCA-treated db/db mice (Fig. 4A and B). Suppressing
ER stress by TUDCA also led to a great increase in ACC
phosphorylation at the AMPK-mediated phosphorylation
site (Ser
79) (Fig. 4A and C). A similar increase in AMPK
activation was observed in the liver of TUDCA treated
db/db mice (Fig. 4D–F). To determine whether DsbA-L has
an effect on insulin signaling, we infected 3T3-L1-CAR
adipocytes with adenoviruses encoding GFP or GFP plus
DsbA-L. We found that overexpression of DsbA-L in-
creased the cellular levels and secretion of adiponectin
and enhanced resistance to TG-induced ER stress (Fig.
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FIG. 3. ER stress or DsbA-L knockdown suppresses adiponectin levels by
inducing autophagy-dependent degradation. A: DsbA-L-suppressed or
scramble control 3T3–L1 adipocytes were treated with 3-MA (5 mol/l) or
vehicle for 24 h as indicated. The protein levels of adiponectin, DsbA-L,
and LC3 in cell lysates were determined by Western blot using speciﬁc
antibodies as indicated. -tubulin was used as a loading control. Adi-
ponectin levels in conditioned medium (C.M.) were determined with an
antiadiponectin antibody. The data represent three independent experi-
ments with similar results. B: The 3T3–L1 adipocytes were pretreated
with () or without () 3-MA (5 mol/l) for 1 h, followed by TG (0.01
mol/l) for different times as indicated. The protein levels of adiponectin,
LC3, and -tubulin were determined by Western blot analysis with
speciﬁc antibodies as indicated. Adiponectin levels in conditioned me-
dium (C.M.) were determined with an antiadiponectin antibody. The
mRNA levels of adiponectin (C) were determined by quantitative reverse
transcription PCR; N  3, *P < 0.05; ns, no statistical difference. D:
Differentiated 3T3–L1 adipocytes were treated with TG (0.01 mol/l) or
vehicle for 36 h, and then ﬁxed. The cellular localization of adiponectin
(Adpn, red) was determined by immunoﬂuorescence-staining with a
speciﬁc antibody to the protein. The cellular localization of GFP-LC3 was
observed by green ﬂuorescent protein ﬂuorescence. In each experiment,
more than 100 cells from each group were checked, and 70% of the cells
showed a similar pattern. The data represent three independent experi-
ments with similar results. (A high-quality digital representation of this
ﬁgure is available in the online issue.)
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Consistent with the result that suppressing ER stress
increased insulin signaling, insulin tolerance test experi-
ments showed that TUDCA treatment increased insulin
sensitivity in db/db mice (online supplemental Fig S3A).
TUDCA treatment did not stimulate AMPK activation in
cultured C2C12 myotubes and murine hepatocytes (online
supplemental Fig. S4), suggesting that the increased
AMPK/ACC phosphorylation and insulin sensitivity in vivo
is not caused by a direct stimulatory effect of this chemical
chaperone.
DISCUSSION
It is well documented that the cellular and serum levels of
adiponectin are negatively correlated with obesity. How-
ever, the precise underlying mechanisms remain unclear.
Obesity leads to a low-grade chronic inﬂammatory state
accompanied by increased production of proinﬂammatory
cytokines such as TNF- and interleukin (IL)-6, which
have been shown to reduce adiponectin gene expression
(15,20,21). Obesity also results in a hypoxic microenviron-
ment (22,23), leading to increased ER stress and attenu-
ated adiponectin promoter activity (15). In the present
study, we show that inducing ER stress is sufﬁcient to
decrease the protein levels of adiponectin in 3T3-L1 adi-
pocytes (Fig. 2), suggesting a causative role of ER stress in
downregulating the cellular levels of adiponectin. Consis-
tent with this view, inhibiting ER stress by the chemical
chaperone TUDCA partially restores adiponectin levels
in both db/db mice (Fig. 1) and HFD-induced obese mice
(online supplemental Fig. S2). Our results are in agree-
ment with an earlier ﬁnding that treating the db/db
mice with peroxisome proliferator–activated receptor
(PPAR)/ dual agonist macelignan, which reduces ER
stress, increases adiponectin expression in adipose tis-
sue of db/db mice (24).
Obesity reduces the cellular levels of PPAR, which has
been shown to downregulate adiponectin transcription
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FIG. 4. Inhibition of ER stress improves adiponectin signaling in
db/db mice. A: The expression levels and phosphorylation of
AMPK (Thr
172) and ACC (Ser
79) in skeletal muscle of TUDCA- or
saline-treated db/db mice were determined by Western blot with
speciﬁc antibodies as indicated. The relative AMPK (B) and ACC
(C) phosphorylation levels were quantiﬁed and analyzed (*P <
0.05, n  4). D: The expression levels and phosphorylation of
AMPK and ACC in the liver of TUDCA- or saline-treated db/db
mice were determined by Western blot with speciﬁc antibodies as
indicated. The relative AMPK (E) and ACC (F) phosphorylation
levels were quantiﬁed and analyzed (*P < 0.05, ***P < 0.001, n 
4). G: 3T3–L1-CAR adipocytes were infected with adenoviruses
encoding GFP or GFP plus myc-DsbA-L for 24 h. The cells were
then pretreated with or without TG (0.01 mol/l) for 24 h as indicated, followed with or without 10 nmol/l insulin stimulation for 5 min. The
expression levels of myc-tagged DsbA-L, Akt, and phosphor-Akt (Thr
308) in cell lysates were determined by Western blot with speciﬁc antibodies
as indicated. -tubulin was used as a loading control. The experiment represents three independent experiments with similar results.
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PPAR by pioglitazone treatment increased plasma levels
of adiponectin in human subjects, but had no effect on
adiponectin expression in adipose tissue (26), suggesting
that the primary effect of PPAR may be to promote
adiponectin assembly and secretion, rather than transcrip-
tion. Consistent with this notion, treating adipocytes with
PPAR agonists increased the synthesis and secretion of
HMW adiponectin without affecting mRNA expression and
protein synthesis of this adipokine (5,27). A likely mecha-
nism by which PPAR enhances adiponectin cellular lev-
els and secretion is to increase the expression levels of ER
chaperones such as Ero1-l, which have been shown to
promote adiponectin assembly and secretion in mature
adipocytes and in mice (5,7). Interestingly, we recently
found that treating 3T3-L1 adipocytes with rosiglitazone
increases the expression levels of DsbA-L (10). Since
suppressing DsbA-L leads to ER stress and adiponectin
downregulation (Fig. 2A), these results suggest that
DsbA-L may enhance adiponectin stability and secretion
by enhancing ER function.
In obesity, the cellular levels of DsbA-L are reduced
(10), which may contribute to increased adiponectin mis-
folding in the ER and blockage of this adipokine to form
HMW multimers necessary for secretion. The obesity-
induced accumulation of misfolded molecules in the ER
may result in ER stress and UPR, which in turn lead to
degradation of incorrectly folded proteins by either the
proteasome- or autophagy-associated protein degradation
pathway (28,29). We found that treating the ER-stressed
3T3-L1 cells with 3MA, but not MG132, greatly rescued
adiponectin levels (Fig. 3), suggesting that ER stress–
induced adiponectin downregulation is mediated by an
autophagy-dependent mechanism. Our data showed that
the expression levels of endogenous DsbA-L were reduced
in TG-treated cells (Fig. 1E), suggesting that DsbA-L
reduction is a consequence of ER stress. This result is
consistent with our previous ﬁnding that DsbA-L expres-
sion levels are negatively correlated with obesity in both
obese human subjects and animal models of obesity (10).
Interestingly, we also found that ER stress is increased in
DsbA-L–suppressed cells (Figs. 2A and 3A). One possible
explanation for these seemly contradictory results is that
DsbA-L plays a critical role in the maintenance of cell
homeostasis, probably functioning as a chaperone to fa-
cilitate correct folding and assembly of adiponectin and
potentially other macromolecules in the ER, where trans-
membrane and secreted proteins are synthesized, assem-
bled, and/or modiﬁed. Thus, reducing its expression levels
may lead to overloading of incorrectly-folded proteins,
resulting in ER stress and subsequent activation of an
autophagy-dependent protein-degradation pathway. Thus,
the negative effect of obesity on adiponectin levels may be
twofold: obesity leads to overloading of misfolded adi-
ponectin in the ER, which may induce ER stress–induced
degradation. Obesity also downregulates DsbA-L, thus
accelerating adiponectin misfolding and degradation by
diminishing the protective chaperone activity of DsbA-L.
Consistent with this model, overexpression of DsbA-L
promotes the assembly of the HMW form of adiponectin
and prevents ER stress–induced adiponectin downregula-
tion (Fig. 2B and C).
In conclusion, we have presented evidence showing that
inducing ER stress is sufﬁcient to cause adiponectin
degradation in 3T3-L1 adipocytes. In addition, we show
that DsbA-L has a protective role in ER stress–induced
adiponectin downregulation. Since DsbA-L levels are re-
duced in obese human subjects and animal models of
obesity (10), reduction of DsbA-L could be a mechanism
by which obesity downregulates adiponectin levels and
secretion, contributing to increased insulin resistance. We
previously showed that the cellular levels of DsbA-L are
stimulated by the PPAR agonist rosiglutazone (10), sug-
gesting that increasing the expression levels of this protein
could be a promising approach to increase adiponectin
multimerization and insulin sensitivity.
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